The group of stocks that are the focus of today’s article have been experiencing an incredible run-up this year, with their outperformance likely attributable to the rising expectations of Joe […]read more
A deluge of data for various COVID-19 vaccine candidates is expected in the next month or two, and today’s article notes that strategists at Goldman Sachs believe that this “vaccine […]read more
“Smart investors will look for biotech stocks that have drug pipelines full of good prospects, as well as balance sheets strong enough to withstand any unforeseen problems,” acknowledges the author […]read more
Having Posted Tremendous Gains In Recent Months, Are Either Of These 2 Small-Cap Biotech Stocks Buys?
“This year didn’t start out with a bang for these two biotechs, but their performances over the past few months have been breathtaking,” observes the author of today’s article in […]read more
Investors looking for a post-election idea may want to consider the ETF highlighted in today’s article, which tracks an index “comprised of small- and mid-cap stocks of biotechnology companies that […]read more
Today’s article highlights a plethora of new stocks to watch in the biotech, tech, cleantech, psychedelics and cannabis spaces, among others. In regards to the biotech names, the author notes […]read more
For those interested in biotech penny stocks, today’s article highlights four to watch, two of which are up over 140% year-to-date. For these four biotech penny stocks – which include […]read more